This application is in response to RFA 86-CA-10, National Collaborative Imaging Trails Projects. We have orgainzed a group of institutions to form the Radiologic Diagnostic Oncology Group (RDOG). This institution is a part of that group. The collaborative group will be designed to provided a means whereby efficacy studies on new diagnostic imaging tests can be instituted in a timely fashion and whereby data can be analyzed in an accurate manner. Under the auspices of an operations center and statistical and data management group, we will establish an ongoing mechanism to: optimize image quality across all participating sites; obtain consistent and complete data across participating sites; create a film library to allow derivative studies in subsequent years; and analyze imaging data for clinical effectiveness and potential algorithm development using appropriate analytic techniques. The techniques employed for analysis will be state-of-the-art involving receiver operating characteristic curve analyses; special care will be taken to ensure correction for a number of biases that might preclude accurate data analyses. The application addresses the staging of both lung and prostate cancer. The absolute value of plain radiographs, CT and MRI in the staging of patients with non-small-cell bronchogenic caracinoma will be determined; the incremental value of MRI over CT also be assessed. For staging prostate cancer, the accuracy of MRI and transectal sonography will be determined in both absolute and incremental ways.
| Webb, W R; Sarin, M; Zerhouni, E A et al. (1993) Interobserver variability in CT and MR staging of lung cancer. J Comput Assist Tomogr 17:841-6 |
| Webb, W R; Gatsonis, C; Zerhouni, E A et al. (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178:705-13 |
